Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 22
Filter
Add more filters










Publication year range
1.
Science ; 345(6201): 1130, 2014 Sep 05.
Article in English | MEDLINE | ID: mdl-25190789

ABSTRACT

We appreciate the interest in our paper and the opportunity to clarify theoretical and technical aspects describing the influence of Donnan equilibria on neuronal chloride ion (Cl(-)) distributions.


Subject(s)
Brain/metabolism , Chloride Channels/metabolism , Chlorides/metabolism , Neurons/metabolism , Receptors, GABA-A/metabolism , Animals
2.
Science ; 343(6171): 670-5, 2014 Feb 07.
Article in English | MEDLINE | ID: mdl-24503855

ABSTRACT

Neuronal intracellular chloride concentration [Cl(-)](i) is an important determinant of γ-aminobutyric acid type A (GABA(A)) receptor (GABA(A)R)-mediated inhibition and cytoplasmic volume regulation. Equilibrative cation-chloride cotransporters (CCCs) move Cl(-) across the membrane, but accumulating evidence suggests factors other than the bulk concentrations of transported ions determine [Cl(-)](i). Measurement of [Cl(-)](i) in murine brain slice preparations expressing the transgenic fluorophore Clomeleon demonstrated that cytoplasmic impermeant anions ([A](i)) and polyanionic extracellular matrix glycoproteins ([A](o)) constrain the local [Cl(-)]. CCC inhibition had modest effects on [Cl(-)](i) and neuronal volume, but substantial changes were produced by alterations of the balance between [A](i) and [A](o). Therefore, CCCs are important elements of Cl(-) homeostasis, but local impermeant anions determine the homeostatic set point for [Cl(-)], and hence, neuronal volume and the polarity of local GABA(A)R signaling.


Subject(s)
Brain/metabolism , Chloride Channels/metabolism , Chlorides/metabolism , Neurons/metabolism , Receptors, GABA-A/metabolism , Animals , Cell Membrane Permeability , Cell Polarity , Cytoplasm/metabolism , Extracellular Matrix Proteins/metabolism , Glycoproteins/metabolism , Mice , Mice, Transgenic , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/metabolism , Signal Transduction
3.
Neurobiol Dis ; 38(3): 482-91, 2010 Jun.
Article in English | MEDLINE | ID: mdl-20149872

ABSTRACT

Inflammation has been associated with the two classic lesions in the Alzheimer's (AD) brain, amyloid deposits and neurofibrillary tangles. Recent data suggest that Triflusal, a compound with potent anti-inflammatory effects in the central nervous system in vivo, might delay the conversion from amnestic mild cognitive impairment to a fully established clinical picture of dementia. In the present study, we investigated the effect of Triflusal on brain Abeta accumulation, neuroinflammation, axonal curvature and cognition in an AD transgenic mouse model (Tg2576). Triflusal treatment did not alter the total brain Abeta accumulation but significantly reduced dense-cored plaque load and associated glial cell proliferation, proinflammatory cytokine levels and abnormal axonal curvature, and rescued cognitive deficits in Tg2576 mice. Behavioral benefit was found to involve increased expression of c-fos and BDNF, two of the genes regulated by CREB, as part of the signal transduction cascade underlying the molecular basis of long-term potentiation. These results add preclinical evidence of a potentially beneficial effect of Triflusal in AD.


Subject(s)
Alzheimer Disease/drug therapy , Alzheimer Disease/metabolism , Brain/drug effects , Brain/metabolism , Central Nervous System Agents/pharmacology , Salicylates/pharmacology , Alzheimer Disease/pathology , Amyloid beta-Peptides/genetics , Amyloid beta-Peptides/metabolism , Animals , Axons/drug effects , Axons/pathology , Brain/pathology , Brain-Derived Neurotrophic Factor/metabolism , Cognition Disorders/drug therapy , Cognition Disorders/metabolism , Cognition Disorders/pathology , Cytokines/metabolism , Disease Models, Animal , Humans , Mice , Mice, Inbred C57BL , Mice, Transgenic , Neuroglia/drug effects , Neuroglia/pathology , Plaque, Amyloid/drug effects , Plaque, Amyloid/metabolism , Plaque, Amyloid/pathology , Proto-Oncogene Proteins c-fos/metabolism
4.
Phys Med Biol ; 54(20): 6201-16, 2009 Oct 21.
Article in English | MEDLINE | ID: mdl-19794239

ABSTRACT

Amyloid-beta plaques are an Alzheimer's disease biomarker which present unique challenges for near-infrared fluorescence tomography because of size (<50 microm diameter) and distribution. We used high-resolution simulations of fluorescence in a digital Alzheimer's disease mouse model to investigate the optimal fluorophore and imaging parameters for near-infrared fluorescence tomography of amyloid plaques. Fluorescence was simulated for amyloid-targeted probes with emission at 630 and 800 nm, plaque-to-background ratios from 1-1000, amyloid burden from 0-10%, and for transmission and reflection measurement geometries. Fluorophores with high plaque-to-background contrast ratios and 800 nm emission performed significantly better than current amyloid imaging probes. We tested idealized fluorophores in transmission and full-angle tomographic measurement schemes (900 source-detector pairs), with and without anatomical priors. Transmission reconstructions demonstrated strong linear correlation with increasing amyloid burden, but underestimated fluorescence yield and suffered from localization artifacts. Full-angle measurements did not improve upon the transmission reconstruction qualitatively or in semi-quantitative measures of accuracy; anatomical and initial-value priors did improve reconstruction localization and accuracy for both transmission and full-angle schemes. Region-based reconstructions, in which the unknowns were reduced to a few distinct anatomical regions, produced highly accurate yield estimates for cortex, hippocampus and brain regions, even with a reduced number of measurements (144 source-detector pairs).


Subject(s)
Alzheimer Disease/pathology , Amyloid beta-Peptides/metabolism , Spectrometry, Fluorescence/methods , Spectrophotometry, Infrared/methods , Animals , Brain/pathology , Calibration , Disease Models, Animal , Humans , Image Processing, Computer-Assisted/methods , Mice , Mice, Transgenic , Models, Statistical , Optics and Photonics , Reproducibility of Results
5.
J Neurochem ; 102(4): 1095-104, 2007 Aug.
Article in English | MEDLINE | ID: mdl-17472706

ABSTRACT

Alzheimer's disease (AD) is characterized by senile plaques and neurodegeneration although the neurotoxic mechanisms have not been completely elucidated. It is clear that both oxidative stress and inflammation play an important role in the illness. The compound curcumin, with a broad spectrum of anti-oxidant, anti-inflammatory, and anti-fibrilogenic activities may represent a promising approach for preventing or treating AD. Curcumin is a small fluorescent compound that binds to amyloid deposits. In the present work we used in vivo multiphoton microscopy (MPM) to demonstrate that curcumin crosses the blood-brain barrier and labels senile plaques and cerebrovascular amyloid angiopathy (CAA) in APPswe/PS1dE9 mice. Moreover, systemic treatment of mice with curcumin for 7 days clears and reduces existing plaques, as monitored with longitudinal imaging, suggesting a potent disaggregation effect. Curcumin also led to a limited, but significant reversal of structural changes in dystrophic dendrites, including abnormal curvature and dystrophy size. Together, these data suggest that curcumin reverses existing amyloid pathology and associated neurotoxicity in a mouse model of AD. This approach could lead to more effective clinical therapies for the prevention of oxidative stress, inflammation and neurotoxicity associated with AD.


Subject(s)
Alzheimer Disease , Curcumin/metabolism , Curcumin/therapeutic use , Neurites/drug effects , Neuroprotective Agents/metabolism , Neuroprotective Agents/therapeutic use , Alzheimer Disease/metabolism , Alzheimer Disease/pathology , Alzheimer Disease/prevention & control , Amyloid beta-Peptides/metabolism , Amyloid beta-Protein Precursor/genetics , Animals , Disease Models, Animal , Enzyme-Linked Immunosorbent Assay , Female , Male , Mice , Mice, Inbred C57BL , Mice, Transgenic , Neurons/pathology , Presenilin-1/genetics
7.
J Neuropathol Exp Neurol ; 62(2): 137-45, 2003 Feb.
Article in English | MEDLINE | ID: mdl-12578223

ABSTRACT

Postmortem analyses of senile plaques reveal numerous dystrophic processes in their vicinity. We used in vivo multiphoton microscopy of a transgenic model of Alzheimer disease (AD) to simultaneously image senile plaques and nearby neuronal processes. Plaques were labeled by immunofluorescent staining or thioflavine-S and neuronal processes were labeled with a fluorescent dextran conjugate. Imaging of 3-dimensional volumes in the vicinity of plaques revealed subtle changes in neurite geometry in or near diffuse plaques. By contrast, disruptions in neurite morphology, including dystrophic neurites immediately surrounding plaques as well as major alterations in neurite trajectories, were seen in association with thioflavine-S-positive plaques. Nearly half of all labeled processes that came within 50 microm of a thioflavine-S-positive plaque were altered, suggesting a fairly large "halo" of neuropil alterations that extend beyond the discrete border of a thioflavine-S plaque. These results support the hypothesis that compact thioflavine-S-positive plaques disrupt the neuropil in AD.


Subject(s)
Alzheimer Disease/metabolism , Cerebral Cortex/metabolism , Neurites/metabolism , Plaque, Amyloid/metabolism , Thiazoles/metabolism , Aging/metabolism , Aging/pathology , Alzheimer Disease/pathology , Alzheimer Disease/physiopathology , Amyloid beta-Peptides/metabolism , Animals , Axons/metabolism , Axons/pathology , Benzothiazoles , Cerebral Cortex/pathology , Cerebral Cortex/physiopathology , Dendrites/metabolism , Dendrites/pathology , Dextrans , Disease Models, Animal , Fluorescent Dyes , Mice , Mice, Inbred C57BL , Mice, Transgenic , Microscopy, Fluorescence, Multiphoton , Neurites/pathology , Neuropil/metabolism , Neuropil/pathology , Plaque, Amyloid/pathology
9.
J Neuropathol Exp Neurol ; 60(3): 274-9, 2001 Mar.
Article in English | MEDLINE | ID: mdl-11245211

ABSTRACT

Transgenic mice overexpressing the human amyloid precursor protein (APPV717F) develop cerebral amyloid angiopathy (CAA) as they age. We have examined the effect of CAA on blood vessels in vivo using multiphoton laser scanning microscopy. We are able to simultaneously detect, in an alive but anesthetized animal, fluorescent angiography of microvessels as well as the presence of amyloid angiopathy in 3-dimensional volumes near the surface of the brain. Analysis revealed dilation of the portions of vessels that were associated with amyloid deposition, even when that amyloid deposition was quite mild. In addition, analysis of the 3-dimensional reconstruction of the relationship between the vasculature and CAA suggest that CAA is initiated close to branch points of vessels. Taken together, these data suggest that CAA has a substantial effect on the physiology of the microvasculature in vivo.


Subject(s)
Alzheimer Disease/pathology , Cerebral Amyloid Angiopathy/pathology , Cerebral Cortex/pathology , Microcirculation/pathology , Microscopy, Confocal/methods , Animals , Disease Models, Animal , Female , Image Processing, Computer-Assisted/methods , Mice , Mice, Transgenic
10.
J Neurosci ; 21(3): 858-64, 2001 Feb 01.
Article in English | MEDLINE | ID: mdl-11157072

ABSTRACT

In Alzheimer's disease, amyloid-beta peptide aggregates in the extracellular space to form senile plaques. The process of plaque deposition and growth has been modeled on the basis of in vitro experiments in ways that lead to divergent predictions: either a diffusion-limited growth model in which plaques grow by first-order kinetics, or a dynamic model of continual deposition and asymmetrical clearance in which plaques reach a stable size and stop growing but evolve morphologically over time. The models have not been tested in vivo because plaques are too small (by several orders of magnitude) for conventional imaging modalities. We now report in vivo multiphoton laser scanning imaging of thioflavine S-stained senile plaques in the Tg2576 transgenic mouse model of Alzheimer's disease to test these biophysical models and show that there is no detectable change in plaque size over extended periods of time. Qualitatively, geometric features remain unchanged over time in the vast majority of the 349 plaques imaged and re-imaged. Intervals as long as 5 months were obtained. Nonetheless, rare examples of growth or shrinkage of individual plaques do occur, and new plaques appear between imaging sessions. These results indicate that thioflavine S-positive plaques appear and then are stable, supporting a dynamic feedback model of plaque growth.


Subject(s)
Alzheimer Disease/pathology , Microscopy/methods , Plaque, Amyloid/metabolism , Plaque, Amyloid/pathology , Animals , Benzothiazoles , Disease Models, Animal , Disease Progression , Feedback , Fluorescent Dyes , Image Processing, Computer-Assisted , Male , Mice , Mice, Transgenic , Microscopy/instrumentation , Thiazoles/metabolism
11.
Proc Natl Acad Sci U S A ; 97(21): 11551-6, 2000 Oct 10.
Article in English | MEDLINE | ID: mdl-11016955

ABSTRACT

The low density lipoprotein receptor-related protein (LRP) is an endocytic receptor that is a member of the low density lipoprotein receptor family. We report that the LRP ligand, activated alpha(2)-macroglobulin (alpha(2)M*), induces robust calcium influx in cultured primary neurons, but not in nonneuronal LRP-containing cells in the same culture. The calcium influx is mediated through N-methyl-d-aspartate receptor channels, which explains the neuron specificity of the response. Microapplication of alpha(2)M* leads to a localized response at the site of application that dissipates rapidly, suggesting that the calcium signal is temporally and spatially discrete. Calcium influx to alpha(2)M* is blocked by the physiological LRP inhibitor, receptor-associated protein. Bivalent antibodies to the extracellular domain of LRP, but not Fab fragments of the same antibody, cause calcium influx, indicating that the response is specific to LRP and may require dimerization of the receptor. Thus, LRP is an endocytic receptor with a novel signaling role.


Subject(s)
Calcium Signaling/physiology , Endocytosis , Neurons/metabolism , Receptors, Immunologic/physiology , Receptors, N-Methyl-D-Aspartate/physiology , Animals , Calcium Channel Blockers/pharmacology , Cells, Cultured , Dizocilpine Maleate/pharmacology , Excitatory Amino Acid Antagonists/pharmacology , Low Density Lipoprotein Receptor-Related Protein-1 , Mice , Microscopy, Confocal , Receptors, N-Methyl-D-Aspartate/antagonists & inhibitors
12.
J Neuroimmunol ; 108(1-2): 227-35, 2000 Aug 01.
Article in English | MEDLINE | ID: mdl-10900358

ABSTRACT

Inflammatory mediators have been implicated in the pathophysiology of neurodegenerative diseases. Here we report the presence of the chemokine receptor CXCR3 and its ligand, IP-10, in normal and Alzheimer's disease (AD) brains. CXCR3 was detected constitutively on neurons and neuronal processes in various cortical and subcortical regions; IP-10 was observed in a subpopulation of astrocytes in normal brain, and was markedly elevated in astrocytes in AD brains. Many IP-10(+) astrocytes were associated with senile plaques and had an apparently coordinated upregulation of MIP-1beta. Moreover, we showed that CXCR3 ligands, IP-10 and Mig, were able to activate ERK1/2 pathway in mouse cortical neurons, suggesting a novel mechanism of neuronal-glial interaction.


Subject(s)
Alzheimer Disease/enzymology , Astrocytes/metabolism , Chemokines, CXC/metabolism , Intercellular Signaling Peptides and Proteins , Mitogen-Activated Protein Kinases/metabolism , Neurons/metabolism , Receptors, Chemokine/metabolism , Aged , Alzheimer Disease/metabolism , Alzheimer Disease/pathology , Animals , Astrocytes/cytology , Astrocytes/enzymology , Astrocytes/pathology , Cells, Cultured , Cerebral Cortex/cytology , Cerebral Cortex/drug effects , Cerebral Cortex/metabolism , Cerebral Cortex/pathology , Chemokine CCL4 , Chemokine CXCL10 , Chemokine CXCL9 , Chemokines, CXC/pharmacology , Enzyme Activation/drug effects , Female , Gene Expression Profiling , Glial Fibrillary Acidic Protein/metabolism , Humans , Ligands , MAP Kinase Signaling System/drug effects , Macrophage Inflammatory Proteins/metabolism , Mice , Neurons/cytology , Neurons/enzymology , Neurons/pathology , Phosphorylation/drug effects , Plaque, Amyloid/enzymology , Plaque, Amyloid/metabolism , Plaque, Amyloid/pathology , Receptors, CXCR3 , Up-Regulation
13.
J Neurochem ; 71(4): 1471-81, 1998 Oct.
Article in English | MEDLINE | ID: mdl-9751180

ABSTRACT

N-Methyl-D-aspartate (NMDA) receptors mediate increases in intracellular calcium that can be modulated by protein kinase C (PKC). As PKC modulation of NMDA receptors in neurons is complex, we studied the effects of PKC activation on recombinant NMDA receptor-mediated calcium rises in a nonneuronal mammalian cell line, human embryonic kidney 293 (HEK-293). Phorbol 12-myristate 13-acetate (PMA) pretreatment of HEK-293 cells enhanced or suppressed NMDA receptor-mediated calcium rises based on the NMDA receptor subunit composition. NR2A or NR2B, in combination with NR1(011), conveyed enhancement whereas NR2C and NR2D conveyed suppression. The PKC inhibitor bisindolylmaleimide blocked each of these effects. The region on NR2A that conveyed enhancement localized to a discrete segment of the C terminus distal to the portion of NR2C that is homologous to NR2A. Calcium-45 accumulation, but not intracellular calcium store depletion, matched PMA effects on NMDA receptor-mediated calcium changes, suggesting that these effects were not due to effects on intracellular calcium stores. The suppression of intracellular calcium transients seen with NR2C was eliminated when combined with NR1 splice variants lacking C-terminal cassette 1. Thus, the intracellular calcium effects of PMA were distinguishable based on both the NR1 splice variant and the NR2 subunit type that were expressed. Such differential effects resemble the diversity of PKC effects on NMDA receptors in neurons.


Subject(s)
Protein Kinase C/physiology , Receptors, N-Methyl-D-Aspartate/metabolism , Calcium/metabolism , Cell Line , Enzyme Activation/drug effects , Enzyme Activation/genetics , Humans , Indoles/pharmacology , Kidney/cytology , Kidney/enzymology , Kidney/metabolism , Maleimides/pharmacology , Mutagenesis, Site-Directed , Protein Kinase C/antagonists & inhibitors , Protein Kinase C/metabolism , Receptors, N-Methyl-D-Aspartate/drug effects , Receptors, N-Methyl-D-Aspartate/genetics , Tetradecanoylphorbol Acetate/pharmacology , Thapsigargin/pharmacology , Transfection
14.
J Biol Chem ; 272(1): 647-56, 1997 Jan 03.
Article in English | MEDLINE | ID: mdl-8995308

ABSTRACT

N-methyl-D-aspartate (NMDA) receptors can mediate cell death in neurons and in non-neuronal cells that express recombinant NMDA receptors. In neurons, increases in intracellular calcium correlate with NMDA receptor-mediated death, supporting a key role for loss of cellular calcium homeostasis in excitotoxic cell death. In the present study, free intracellular calcium concentrations were examined in response to activation of recombinant NMDA receptors expressed in human embryonic kidney 293 cells. Intracellular calcium was measured in transfected cell populations by cotransfection with the calcium-sensitive, bioluminescent protein aequorin and by single cell imaging with the fluorescent calcium indicator fluo-3. Agonist application to NR1/2A or NR1/2B-transfected cells elicited robust rises in intracellular calcium. NR1/2A responses were inhibited by the noncompetitive antagonists MK-801 and dextromethorphan and were dependent on extracellular calcium but not on intracellular calcium stores. In contrast, no detectable intracellular calcium responses were observed in NR1/2C-transfected cells. These findings indicate that NMDA receptors in the absence of other neuron-specific factors can mediate increases in intracellular calcium with subunit specificity and extracellular calcium dependence.


Subject(s)
Calcium/metabolism , Receptors, N-Methyl-D-Aspartate/physiology , Cell Line , Dizocilpine Maleate/pharmacology , Glutamates/pharmacology , Humans , Receptors, N-Methyl-D-Aspartate/antagonists & inhibitors , Receptors, N-Methyl-D-Aspartate/classification , Recombinant Proteins , Serotonin/pharmacology , Signal Transduction , Transfection
15.
Neuron ; 14(1): 19-28, 1995 Jan.
Article in English | MEDLINE | ID: mdl-7826636

ABSTRACT

In lamprey spinal cord, intracellular calcium ([Ca2+]i) plays a key role in mechanisms regulating neuronal activity in the segmental network for locomotion. In this report, measurements of [Ca2+]i with fluo-3 in various regions of motoneurons in the intact spinal cord were obtained on a high speed confocal microscope following electrical stimulation. Likewise, rhythmic calcium fluctuations within dendrites and axons were seen during "fictive swimming" and were directly correlated with electrical activity. Antidromic stimulation of motoneuron axons induced large calcium transients and revealed spatially restricted "hot spots," both of which required external calcium and were blocked by nickel, but not by known calcium channel antagonists. These results suggest that lamprey spinal cord axons may possess a pharmacologically novel class of calcium channel.


Subject(s)
Calcium/metabolism , Microscopy, Confocal , Microscopy, Video , Motor Neurons/metabolism , Aniline Compounds , Animals , Axons/metabolism , Calcium/pharmacology , Calcium Channel Blockers/pharmacology , Dendrites/metabolism , Electric Stimulation , Evoked Potentials , Fluorescent Dyes , Lampreys , Motor Neurons/ultrastructure , Nickel/pharmacology , Spinal Cord/cytology , Swimming , Synapses/physiology , Xanthenes
16.
Neuron ; 13(4): 837-48, 1994 Oct.
Article in English | MEDLINE | ID: mdl-7946332

ABSTRACT

Drosophila phototransduction is a phosphoinositide-mediated and Ca(2+)-regulated signaling cascade ideal for the dissection of feedback regulatory mechanisms. To study the roles of intracellular Ca2+ ([Ca2+]i) in this process, we developed novel techniques for the measurement of [Ca2+]i in intact photoreceptors. We genetically engineered flies that express a UV-specific rhodopsin in place of the normal rhodopsin, so that long wavelength light can be used to image [Ca2+]i changes while minimally exciting the photoreceptor cells. We show that activation with UV generates [Ca2+]i increases that are spatially localized to the rhabdomeres and that are entirely dependent on the influx of extracellular Ca2+. Application of intracellular Ca2+ chelators of varying affinities demonstrates that the Ca2+ influx initially generates a large-amplitude transient that is crucial for negative regulation. Internal Ca2+ stores were revealed by discharging them with thapsigargin. But, in contrast to proposals that IP3-sensitive stores mediate phototransduction, thapsigargin does not mimic or acutely interfere with photoexcitation. Finally, we identify a photoreceptor-specific PKC as essential for normal kinetics of [Ca2+]i recovery.


Subject(s)
Calcium/metabolism , Cytosol/metabolism , Drosophila/metabolism , Photoreceptor Cells, Invertebrate/physiology , Animals , Drosophila/genetics , Electric Conductivity , Extracellular Space/metabolism , Genetic Engineering , Kinetics , Microscopy, Confocal , Photoreceptor Cells, Invertebrate/radiation effects , Photoreceptor Cells, Invertebrate/ultrastructure , Protein Kinase C/metabolism , Rhodopsin/genetics , Rhodopsin/radiation effects , Terpenes/pharmacology , Thapsigargin , Ultraviolet Rays
17.
J Bone Miner Res ; 9(9): 1407-17, 1994 Sep.
Article in English | MEDLINE | ID: mdl-7817824

ABSTRACT

We previously demonstrated that the [Ca2+]i response to PTH is heterogeneous in single UMR-106-01 osteogenic sarcoma cells. To verify whether response heterogeneity is a universal feature of PTH signal transduction, cAMP production was monitored in monolayer cultures of UMR-106-01 cells and human trabecular bone osteoblasts (HOB) using the cAMP-sensitive fluorescent indicator FlCRhR. FlCRhR was microinjected into single cells, and the 500-530/> 560 nm fluorescence ratio was monitored by confocal laserscanning video imaging as a measure of cAMP concentration ([cAMP]). Virtually all UMR-106-01 cells exposed to bovine PTH(1-34) (10(-7) M) exhibited an increase in intracellular [cAMP], with an average fluorescence ratio change of 145 +/- 17% of baseline (n = 15), corresponding to nearly maximal dissociation of protein kinase A. In the continued presence of the hormone (10(-7) M), [cAMP] remained elevated for at least 30 minutes. This effect was accompanied by a slow translocation of the fluorescein-labeled catalytic subunit of protein kinase A from the cytoplasm to the nucleus. In contrast, PTH(1-34) caused no detectable increase in [cAMP] in HOB cells, although PGE2 (3 x 10(-6) M) stimulation was able to increase the FlCRhR ratio (154 +/- 27%, n = 10). The truncated fragment PTH(2-34) was only 67% as potent at PTH(1-34), but deletion of the first two amino acids at the N terminus abolished the hormone's ability to stimulate cAMP production in UMR-106-01 cells. Brief exposure to 10(-7) M of either PTH(3-34) or PTH(7-34) did not affect the amplitude of the fluorescence ratio change induced by equimolar doses of PTH(1-34). Thus, in osteoblast-like cells stimulated with PTH, the [cAMP] response is much more homogeneous from cell to cell than the [Ca2+]i response.


Subject(s)
Cyclic AMP/metabolism , Osteoblasts/drug effects , Parathyroid Hormone/pharmacology , Peptide Fragments/pharmacology , Animals , Bone Neoplasms/pathology , Calcium/metabolism , Cyclic AMP-Dependent Protein Kinases/metabolism , Fluorescent Dyes/administration & dosage , Fluorescent Dyes/chemistry , Humans , Image Processing, Computer-Assisted , Microinjections , Microscopy, Confocal , Microscopy, Fluorescence , Osteosarcoma/pathology , Rats , Signal Transduction/drug effects , Teriparatide , Tumor Cells, Cultured
18.
Trends Cell Biol ; 3(7): 242-5, 1993 Jul.
Article in English | MEDLINE | ID: mdl-14731760
19.
Science ; 260(5105): 222-6, 1993 Apr 09.
Article in English | MEDLINE | ID: mdl-7682336

ABSTRACT

Cyclic adenosine monophosphate (cAMP)-dependent protein kinase, labeled with fluorescein and rhodamine on the catalytic and regulatory subunits, respectively, was injected into Aplysia sensory neurons either in culture or in intact cell clusters. Energy transfer between the subunits, a measure of cytosolic cAMP concentration ([cAMP]), and compartmentation of the dissociated subunits were monitored by confocal fluorescence microscopy. Bath application of serotonin produced a much greater elevation of [cAMP] in the processes than in the central bodies of the neurons. The resulting gradients must drive a sizable centripetal flux of cAMP because direct microinjection of cAMP showed that it diffused readily. Perinuclear increases in [cAMP] slowly caused the translocation of the freed catalytic subunit into the nucleus to an extent proportional to the percentage of its dissociation from the regulatory subunit.


Subject(s)
Cyclic AMP/metabolism , Neurons, Afferent/metabolism , Protein Kinases/metabolism , 1-Methyl-3-isobutylxanthine/pharmacology , Animals , Aplysia , Cell Compartmentation , Cell Nucleus/enzymology , Cell Nucleus/metabolism , Cells, Cultured , Cytoplasm/enzymology , Cytoplasm/metabolism , Diffusion , Fluorescein , Fluoresceins , Microinjections , Neurons, Afferent/drug effects , Neurons, Afferent/enzymology , Rhodamines , Serotonin/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...